Mauro Orlando

Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix

Alfonso Dueñas‐González, Juan José Zarbá, Firuza D. Patel et al. · Journal of Clinical Oncology · 2011 · 468 citations · Full text

Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer

David G. Mutch, Mauro Orlando, T. Goss et al. · Journal of Clinical Oncology · 2007 · 432 citations · Full text

Randomized Phase II Trial of Gefitinib With and Without Pemetrexed as First-Line Therapy in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations

Ying Cheng, Haruyasu Murakami, Pan‐Chyr Yang et al. · Journal of Clinical Oncology · 2016 · 185 citations

A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-small Cell Lung Cancer

José Rodrigues-Pereira, Joo-Hang Kim, Manuel Magallanes et al. · Journal of Thoracic Oncology · 2011 · 94 citations · Full text

Medicine, Trial Comparing Pemetrexed/carboplatin, Clinical Trials +9

Three-arm randomised controlled phase 2 study comparing pemetrexed and erlotinib to either pemetrexed or erlotinib alone as second-line treatment for never-smokers with non-squamous non-small cell lung cancer

Dae Ho Lee, Jung Shin Lee, Sang‐We Kim et al. · European Journal of Cancer · 2013 · 78 citations

Second-line Treatment, Medicine, Pharmacology +7